Bad Blood by John Carreyrou
Bad Blood by John Carreyrou
āChilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.ā āThe New YorkĀ Times Book Review
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: aĀ brilliant Stanford dropout whose startup āunicornā promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmesās worth at an estimated $4.5 billion. There was just one problem: The technology didnāt work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivingsāfrom journalists to their own employees.